FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2201261760> ?p ?o ?g. }

• W2201261760 endingPage "37042" @default.
• W2201261760 startingPage "37028" @default.
• W2201261760 abstract "// Ting-Ting Yan 1,* , Xue-Liang Fu 2,* , Jiao Li 2,* , Ying-Nan Bian 3,* , De-Jun Liu 2 , Rong Hua 2 , Lin-Lin Ren 1 , Cheng-Tao Li 3 ,Yong-Wei Sun 2 , Hao-Yan Chen 1 , Jing-Yuan Fang 1 and Jie Hong 1 1 Division of Gastroenterology and Hepatology, Renji Hospital, Shanghai Institution of Digestive Disease, Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, State Key Laboratory of Oncogene and Related Genes, Shanghai Jiao-Tong University School of Medicine, Shanghai, China 2 Department of Biliary-Pancreatic Surgery, Renji Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China 3 Shanghai Key Laboratory of Forensic Medicine, Institute of Forensic Sciences, Ministry of Justice, Shanghai, China * These authors have contributed equally to this work Correspondence to: Jie Hong, email: // Jing-Yuan Fang, email: // Yong-Wei Sun, email: // Hao-Yan Chen, email: // Keywords : pancreatic cancer, RPL15, metastasis, biomarker, PDAC, Pathology Section Received : April 20, 2015 Accepted : September 17, 2015 Published : October 15, 2015 Abstract Early diagnosis and treatment in pancreatic ductal adenocarcinoma (PDAC) is still a challenge worldwide. The poor survival of PDAC patients mainly due to early metastasis when first diagnosed and lack of prognostic biomarker. Ribosomal protein L15 (RPL15), an RNA-binding protein, is a component of ribosomal 60S subunit. It was reported that RPL15 is dysregulated in various type of cancers. However, little is known about the role of RPL15 in PDAC carcinogenesis and progression. Herein, we clarified RPL15 expression status may serve as an independent prognostic biomarker in three independent PDAC patient cohorts. We found that RPL15 was dramatically decreased in PDAC tissues and cell lines. The high expression of RPL15 was inversely correlated with TNM stage, histological differentiation, T classification and vascular invasion. Low expression of RPL15 was significantly associated with poor overall survival of PDAC patients. Furthermore, we demonstrated that the reduction of RPL15 may promote invasion ability of pancreatic cell by inducing EMT process. In conclusion, decreased RPL15 expression is associated with invasiveness of PDAC cells, and RPL15 expression status may serve as a reliable prognostic biomarker in PDAC patients." @default.
• W2201261760 created "2016-06-24" @default.
• W2201261760 creator A5005496208 @default.
• W2201261760 creator A5014365199 @default.
• W2201261760 creator A5019453814 @default.
• W2201261760 creator A5026999257 @default.
• W2201261760 creator A5033452143 @default.
• W2201261760 creator A5036575569 @default.
• W2201261760 creator A5038827352 @default.
• W2201261760 creator A5044175096 @default.
• W2201261760 creator A5044707901 @default.
• W2201261760 creator A5054869868 @default.
• W2201261760 creator A5061952937 @default.
• W2201261760 creator A5063922467 @default.
• W2201261760 date "2015-10-15" @default.
• W2201261760 modified "2023-10-17" @default.
• W2201261760 title "Downregulation of RPL15 may predict poor survival and associate with tumor progression in pancreatic ductal adenocarcinoma" @default.
• W2201261760 cites W1931150388 @default.
• W2201261760 cites W1964081206 @default.
• W2201261760 cites W1967469764 @default.
• W2201261760 cites W1980097189 @default.
• W2201261760 cites W1993782263 @default.
• W2201261760 cites W1994444354 @default.
• W2201261760 cites W1996667997 @default.
• W2201261760 cites W2001961422 @default.
• W2201261760 cites W2002175672 @default.
• W2201261760 cites W2014868707 @default.
• W2201261760 cites W2021251343 @default.
• W2201261760 cites W2030699054 @default.
• W2201261760 cites W2032326904 @default.
• W2201261760 cites W2035186696 @default.
• W2201261760 cites W2043693757 @default.
• W2201261760 cites W2055170089 @default.
• W2201261760 cites W2060861934 @default.
• W2201261760 cites W2061776806 @default.
• W2201261760 cites W2063764480 @default.
• W2201261760 cites W2066859066 @default.
• W2201261760 cites W2084682588 @default.
• W2201261760 cites W2088412411 @default.
• W2201261760 cites W2095430690 @default.
• W2201261760 cites W2104812266 @default.
• W2201261760 cites W2127028479 @default.
• W2201261760 cites W2128562119 @default.
• W2201261760 cites W2132132957 @default.
• W2201261760 cites W2150298880 @default.
• W2201261760 cites W2150584477 @default.
• W2201261760 cites W2153450196 @default.
• W2201261760 cites W2160391606 @default.
• W2201261760 cites W2164068046 @default.
• W2201261760 cites W2168112142 @default.
• W2201261760 cites W2170552969 @default.
• W2201261760 cites W2404073439 @default.
• W2201261760 cites W4238820556 @default.
• W2201261760 doi "https://doi.org/10.18632/oncotarget.5939" @default.
• W2201261760 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4741913" @default.
• W2201261760 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26498693" @default.
• W2201261760 hasPublicationYear "2015" @default.
• W2201261760 type Work @default.
• W2201261760 sameAs 2201261760 @default.
• W2201261760 citedByCount "29" @default.
• W2201261760 countsByYear W22012617602016 @default.
• W2201261760 countsByYear W22012617602017 @default.
• W2201261760 countsByYear W22012617602018 @default.
• W2201261760 countsByYear W22012617602019 @default.
• W2201261760 countsByYear W22012617602020 @default.
• W2201261760 countsByYear W22012617602021 @default.
• W2201261760 countsByYear W22012617602022 @default.
• W2201261760 countsByYear W22012617602023 @default.
• W2201261760 crossrefType "journal-article" @default.
• W2201261760 hasAuthorship W2201261760A5005496208 @default.
• W2201261760 hasAuthorship W2201261760A5014365199 @default.
• W2201261760 hasAuthorship W2201261760A5019453814 @default.
• W2201261760 hasAuthorship W2201261760A5026999257 @default.
• W2201261760 hasAuthorship W2201261760A5033452143 @default.
• W2201261760 hasAuthorship W2201261760A5036575569 @default.
• W2201261760 hasAuthorship W2201261760A5038827352 @default.
• W2201261760 hasAuthorship W2201261760A5044175096 @default.
• W2201261760 hasAuthorship W2201261760A5044707901 @default.
• W2201261760 hasAuthorship W2201261760A5054869868 @default.
• W2201261760 hasAuthorship W2201261760A5061952937 @default.
• W2201261760 hasAuthorship W2201261760A5063922467 @default.
• W2201261760 hasBestOaLocation W22012617601 @default.
• W2201261760 hasConcept C121608353 @default.
• W2201261760 hasConcept C126322002 @default.
• W2201261760 hasConcept C138885662 @default.
• W2201261760 hasConcept C143998085 @default.
• W2201261760 hasConcept C27206212 @default.
• W2201261760 hasConcept C2779013556 @default.
• W2201261760 hasConcept C2780210213 @default.
• W2201261760 hasConcept C2781197716 @default.
• W2201261760 hasConcept C41260117 @default.
• W2201261760 hasConcept C502942594 @default.
• W2201261760 hasConcept C521751864 @default.
• W2201261760 hasConcept C55493867 @default.
• W2201261760 hasConcept C71924100 @default.
• W2201261760 hasConcept C86803240 @default.
• W2201261760 hasConceptScore W2201261760C121608353 @default.
• W2201261760 hasConceptScore W2201261760C126322002 @default.

• next